SCHEMBL3131276

SCHEMBL3131276

CC(C)(O)CCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3513541 0.80
SCHEMBL1461549 0.78
SCHEMBL37987 0.76 ALDH1A1 (1.00)
SCHEMBL8878328 0.76
SCHEMBL12516732 0.76 ALDH1A1 (0.40)
Ammonia Solution, Strong SCHEMBL28802926 0.72 ALDH1A1 (0.91)
SCHEMBL168273 0.72
Tert-Butanol SCHEMBL4057452 0.72
SCHEMBL9218495 0.69 ALDH1A1 (0.31)
SCHEMBL436635 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106977633-B A kind of vanadium-based catalyst systems for olefinic polymerization 北京引发科技有限公司 2019-08-20 CN claimed
CN-109134716-A A kind of vanadium series catalyst and the method for preparing olefin polymer 北京引发科技有限公司 2019-01-04 CN claimed
CN-106977633-A A kind of vanadium-based catalyst systems for olefinic polymerization 北京引发科技有限公司 2017-07-25 CN claimed
CN-113956133-B Method for synthesizing 25-hydroxy steroid compound, method for preparing side chain thereof and method for preparing side chain intermediate 湖南科瑞生物制药股份有限公司 2025-01-28 CN disclosed
WO-2024133499-A1 GLYCINE DERIVATIVES WITH P2X4 RECEPTOR-BLOCKING ACTIVITY AS DIAGNOSTICS AND FOR THE TREATMENT OF PAIN, INFLAMMATION, CANCER, AND OTHER P2X4 RECEPTOR-RELATED DISEASES RHEINISCHE-FRIEDRICH-WILHELMS-UNIVERSITÄT BONN (DE) 2024-06-27 WO disclosed
US-11840528-B2 Isoxazolyl ether derivatives as GABAA α5 PAM HOFFMANN-LA ROCHE INC. (US) 2023-12-12 US disclosed
CN-113956133-A Synthesis method of 25-hydroxy steroid compound, preparation method of side chain thereof and preparation method of side chain intermediate 湖南科瑞生物制药股份有限公司 2022-01-21 CN disclosed
CN-108699176-B Method for producing polymer and compound containing radical polymerization initiating group 大日精化工业株式会社 2021-11-30 CN disclosed
EP-3807269-A1 NEW ISOXAZOLYL ETHER DERIVATIVES AS GABA A ALPHA5 PAM F. Hoffmann-La Roche AG (CH) 2021-04-21 EP disclosed
US-20210094945-A1 NEW ISOXAZOLYL ETHER DERIVATIVES AS GABA A ALPHA5 PAM HOFFMANN-LA ROCHE INC. (US) 2021-04-01 US disclosed
CN-112424196-A Novel isoxazolyl ether derivatives as GABAA alpha 5 PAM 豪夫迈·罗氏有限公司 2021-02-26 CN disclosed
EP-0619297-B1 Fungicides for the control of take-all desease of plants MONSANTO CO (US) 1997-06-18 EP disclosed
CN-1145029-A Use of xanthine derivatives for reducing the pathological hyperreactivity of eosinophils, xanthine compounds and process for their preparation HOECHST AG (DE) 1997-03-12 CN disclosed
EP-0758239-A1 USE OF XANTHINE DERIVATIVES FOR REDUCING THE PATHOLOGICAL HYPER-REACTIVITY OF EOSINOPHILIC GRANULOCYTES, NOVEL XANTHINE COMPOUNDS AND PROCESS FOR PRODUCING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1997-02-19 EP disclosed
US-5498630-A SUBSTITUTED BENZOTHIOPHENECARBOXAMIDES MONSANTO COMPANY (US) 1996-03-12 US disclosed
WO-1995026727-A1 USE OF XANTHINE DERIVATIVES FOR REDUCING THE PATHOLOGICAL HYPER-REACTIVITY OF EOSINOPHILIC GRANULOCYTES, NOVEL XANTHINE COMPOUNDS AND PROCESS FOR PRODUCING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1995-10-12 WO disclosed
EP-0619297-A1 Fungicides for the control of take-all desease of plants MONSANTO COMPANY (US) 1994-10-12 EP disclosed
WO-1993007751-A1 FUNGICIDES FOR THE CONTROL OF TAKE-ALL DISEASE OF PLANTS MONSANTO COMPANY (US) 1993-04-29 WO disclosed
EP-0538231-A1 Fungicides for the control of take-all disease of plants MONSANTO COMPANY (US) 1993-04-21 EP disclosed
US-4230626-A 25-Halocholest-5-ene-3β,22-diols and esters thereof G. D. SEARLE & CO. (US) 1980-10-28 US disclosed